Sunday, April 18, 2021

Latest:

BCM Docappella performs virtual cover of “Sucker”
Selecting the right deconvolution method just got easier
New clinic provides care, support for patients managing COVID-19 at home
Clinical trial sets out to improve prognosis for pancreatic cancer patients
Closer to human – mouse model more accurately reproduces fatty liver disease

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

cancer transcriptomics

From The Labs

Proteomics analysis identifies potential drug targets for aggressive human cancers

March 4, 2021March 4, 2021 Ana Rodríguez 0 Comments agrressive cancer, cancer proteomics, cancer therapy, cancer transcriptomics, Research

Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.

From the Labs features an image of early physical training of Rett mice, which results in the development of more dendritic arbors or cellular projections in a task-specific group of neurons in the hippocampus (red). Image credit: N.P. Achilly/Zoghbi lab/Nature, 2021.